Copyright
©The Author(s) 2023.
World J Orthop. Jun 18, 2023; 14(6): 443-457
Published online Jun 18, 2023. doi: 10.5312/wjo.v14.i6.443
Published online Jun 18, 2023. doi: 10.5312/wjo.v14.i6.443
Table 3 Change in Hip disability and Osteoarthritis Outcome Score subscale scores (Full analysis set)
Subscale | Hip osteoarthritis (n = 278) – HOOS scale | P valuea | ||||
Visit 1, baseline, n = 278 | Visit 2, week 16-24, n = 272 | Visit 3, week 36-44, n = 271 | Visit 4, week 56-64, n = 270 | Changes from baseline on visit 4 | ||
Pain | 60.97 (58.93-63.02) | 76.36 (74.34-78.38) | 80.89 (78.95-82.84) | 83.63 (81.64-85.62) | 22.81 (20.47-25.16) | < 0.001 |
Symptoms | 61.17 (59.08-63.26) | 73.73 (71.62-75.84) | 78.17 (76.21-80.14) | 81.19 (79.21-83.16) | 19.93 (17.49-22.36) | < 0.001 |
Functional activity of the joint | 65.57 (63.62-67.52) | 78.46 (76.72-80.21) | 81.59 (79.93-83.26) | 84.11 (82.45-85.76) | 18.77 (16.61-20.93) | < 0.001 |
Quality of life | 46.79 (44.72-48.85) | 60.75 (58.50-63.01) | 65.41 (63.09-67.72) | 69.33 (66.83-71.82) | 22.71 (20.14-25.28) | < 0.001 |
- Citation: Lila AM, Alekseeva LI, Baranov AA, Taskina EA, Kashevarova NG, Lapkina NA, Trofimov EA. Chondroitin sulfate and glucosamine combination in patients with knee and hip osteoarthritis: A long-term observational study in Russia. World J Orthop 2023; 14(6): 443-457
- URL: https://www.wjgnet.com/2218-5836/full/v14/i6/443.htm
- DOI: https://dx.doi.org/10.5312/wjo.v14.i6.443